VRAX icon

Virax Biolabs

5 hedge funds and large institutions have $1.14M invested in Virax Biolabs in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 6 closing their positions.

Holders
5
Holders Change
-3
Holders Change %
-37.5%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
2
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
AC
1
Armistice Capital
New York
$1.04M 1,500,000 +1,500,000 New
Legal & General Group
2
Legal & General Group
United Kingdom
$68.4K 99,763 -2,845 -3%
TSS
3
Two Sigma Securities
New York
$17.2K 24,785 +24,785 New
HF
4
HRT Financial
New York
$10K 15,623 +15,623 New
UBS Group
5
UBS Group
Switzerland
$2.13K 3,071 -3,114 -50%
KI
6
Kapitalo Investimentos
Brazil
-117,500 Closed
VF
7
Virtu Financial
New York
-48,458 Closed
Millennium Management
8
Millennium Management
New York
-15,395 Closed
Renaissance Technologies
9
Renaissance Technologies
New York
-11,400 Closed
Morgan Stanley
10
Morgan Stanley
New York
-853 Closed
RAM
11
Riggs Asset Management
Pennsylvania
-4 -100%
CFGS
12
Concourse Financial Group Securities
Alabama